These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Pharmacological treatment of delusional depression]. Amore M; Giordani L; Giorgetti G; Zazzeri N Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200 [TBL] [Abstract][Full Text] [Related]
4. [Serotonin and treatment of mental disorders. Present status and future perspectives]. Sevcík J; Masek K Cas Lek Cesk; 1997 Jul; 136(14):431-3. PubMed ID: 9340186 [TBL] [Abstract][Full Text] [Related]
5. Depression: the case for a monoamine deficiency. Delgado PL J Clin Psychiatry; 2000; 61 Suppl 6():7-11. PubMed ID: 10775018 [TBL] [Abstract][Full Text] [Related]
6. The antidepressant effects of 5-HT uptake inhibitors. Aberg-Wistedt A Br J Psychiatry Suppl; 1989 Dec; (8):32-40. PubMed ID: 2692638 [TBL] [Abstract][Full Text] [Related]
7. [Delusional depression]. Hori M; Shiraishi H Nihon Rinsho; 1994 May; 52(5):1268-72. PubMed ID: 8007399 [TBL] [Abstract][Full Text] [Related]
8. Serotonergic activity in man as a function of pain, pain mechanisms, and depression. Ghia JN; Mueller RA; Duncan GH; Scott DS; Mao W Anesth Analg; 1981 Dec; 60(12):854-61. PubMed ID: 6172060 [TBL] [Abstract][Full Text] [Related]
9. [The relevance of dopamine agonists in the treatment of depression]. Clausius N; Born C; Grunze H Neuropsychiatr; 2009; 23(1):15-25. PubMed ID: 19272288 [TBL] [Abstract][Full Text] [Related]
11. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger]. Pelissolo A; Corruble E Encephale; 2002; 28(4):363-73. PubMed ID: 12232546 [TBL] [Abstract][Full Text] [Related]
12. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. Blier P; de Montigny C; Chaput Y J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):24S-35S. PubMed ID: 3323264 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of serotonin uptake inhibitors in depression. Asberg M; Eriksson B; Mårtensson B; Träskman-Bendz L; Wägner A J Clin Psychiatry; 1986 Apr; 47 Suppl():23-35. PubMed ID: 2937776 [TBL] [Abstract][Full Text] [Related]
14. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder. Hou C; Jia F; Liu Y; Li L Brain Res; 2006 Jun; 1095(1):154-8. PubMed ID: 16713589 [TBL] [Abstract][Full Text] [Related]
15. [Mechanism of action of antidepressants and therapeutic perspectives]. Bourin M; David DJ; Jolliet P; Gardier A Therapie; 2002; 57(4):385-96. PubMed ID: 12422559 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a biochemical lesion in depression. Leonard BE J Clin Psychiatry; 2000; 61 Suppl 6():12-7. PubMed ID: 10775019 [TBL] [Abstract][Full Text] [Related]
17. Psychophysiological correlates of patients with delusional misidentification syndromes and psychotic major depression. Papageorgiou CC; Alevizos B; Ventouras E; Kontopantelis E; Uzunoglu N; Christodoulou G J Affect Disord; 2004 Aug; 81(2):147-52. PubMed ID: 15306140 [TBL] [Abstract][Full Text] [Related]
18. Serotonin and its place in the pathogenesis of depression. Coppen AJ; Doogan DP J Clin Psychiatry; 1988 Aug; 49 Suppl():4-11. PubMed ID: 3045111 [TBL] [Abstract][Full Text] [Related]
19. The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression. Schatzberg AF; Rothschild AJ Ann N Y Acad Sci; 1988; 537():462-71. PubMed ID: 3059936 [No Abstract] [Full Text] [Related]
20. Body image disturbance in body dysmorphic disorder and eating disorders. Obsessions or delusions? Phillips KA; Kim JM; Hudson JI Psychiatr Clin North Am; 1995 Jun; 18(2):317-34. PubMed ID: 7659601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]